United States Congress · 119 session · house
HRES 1285Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
- Status
- In committee
- Latest action
- — Referred to the House Committee on Energy and Commerce.
- Primary sponsor
- Rep. DeGette, Diana [D-CO-1] (D)
- Health
Sponsors
- Rep. DeGette, Diana [D-CO-1] (D) · sponsorprimary
Versions
- Introduced in House